BioCentury
ARTICLE | Politics & Policy

Part D to allow indication-driven formularies

August 29, 2018 10:52 PM UTC

Starting in 2020, CMS will allow Part D plans to include drugs on their formularies on an indication-by-indication basis, according to a memo released Wednesday.

The change would allow plans to only cover certain indications of a drug. Currently, if a Part D plan includes a drug on its formulary, it must cover the drug for every FDA-approved indication...